Paul Calès

19.9k total citations · 3 hit papers
305 papers, 11.5k citations indexed

About

Paul Calès is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Paul Calès has authored 305 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Hepatology, 204 papers in Epidemiology and 60 papers in Surgery. Recurrent topics in Paul Calès's work include Liver Disease Diagnosis and Treatment (192 papers), Liver Disease and Transplantation (138 papers) and Hepatitis C virus research (66 papers). Paul Calès is often cited by papers focused on Liver Disease Diagnosis and Treatment (192 papers), Liver Disease and Transplantation (138 papers) and Hepatitis C virus research (66 papers). Paul Calès collaborates with scholars based in France, United States and Italy. Paul Calès's co-authors include Frédéric Oberti, Jérôme Boursier, Yves Gallois, Jean‐Pierre Pascal, Marie‐Christine Rousselet, Sophie Michalak, I. Fouchard‐Hubert, Christophe Aubé, Victor de Lédinghen and Didier Lebrec and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Applied Physics Letters.

In The Last Decade

Paul Calès

295 papers receiving 11.2k citations

Hit Papers

The severity of nonalcoho... 2012 2026 2016 2021 2015 2012 2015 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul Calès 9.0k 7.7k 2.4k 1.1k 840 305 11.5k
Flemming Bendtsen 8.0k 0.9× 6.5k 0.8× 4.1k 1.7× 1.2k 1.1× 1.3k 1.5× 340 12.1k
Mario Rizzetto 9.0k 1.0× 6.7k 0.9× 1.6k 0.7× 820 0.8× 1.9k 2.3× 148 10.9k
Yogesh Chawla 5.4k 0.6× 5.7k 0.7× 2.8k 1.2× 763 0.7× 768 0.9× 277 8.5k
Diego Vergani 11.2k 1.2× 12.4k 1.6× 4.1k 1.7× 1.2k 1.1× 599 0.7× 417 19.0k
Marshall M. Kaplan 5.8k 0.6× 6.0k 0.8× 3.1k 1.3× 1.1k 1.0× 866 1.0× 143 10.9k
Aleksander Krag 6.3k 0.7× 6.0k 0.8× 2.5k 1.0× 749 0.7× 642 0.8× 232 8.7k
Mario Rizzetto 10.8k 1.2× 8.4k 1.1× 1.3k 0.5× 986 0.9× 1.7k 2.0× 308 13.0k
Shou‐Dong Lee 8.0k 0.9× 8.9k 1.2× 3.4k 1.4× 1.7k 1.5× 394 0.5× 462 14.2k
Annalisa Berzigotti 10.5k 1.2× 10.3k 1.3× 4.3k 1.8× 373 0.3× 682 0.8× 257 13.2k
Juan G. Abraldeṣ 13.8k 1.5× 14.3k 1.9× 7.1k 2.9× 798 0.7× 801 1.0× 280 17.7k

Countries citing papers authored by Paul Calès

Since Specialization
Citations

This map shows the geographic impact of Paul Calès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Calès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Calès more than expected).

Fields of papers citing papers by Paul Calès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Calès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Calès. The network helps show where Paul Calès may publish in the future.

Co-authorship network of co-authors of Paul Calès

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Calès. A scholar is included among the top collaborators of Paul Calès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Calès. Paul Calès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boursier, Jérôme, Charlène Brochard, Sandrine Bertrais, et al.. (2014). Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 40(2). 178–188. 33 indexed citations
2.
Miot, Charline, Élodie Beaumont, Dorothée Duluc, et al.. (2014). IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells. Gut. 64(9). 1466–1475. 50 indexed citations
3.
Boursier, Jérôme, Julien Chaigneau, Fabrice Lainé, et al.. (2011). Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. European Journal of Gastroenterology & Hepatology. 23(11). 974–981. 15 indexed citations
4.
Mahassadi, Alassan Kouamé, et al.. (2010). Diagnostic accuracy of biochemical markers of fibrosis in black African patients with chronic hepatitis B. Health. 2(12). 1413–1420. 3 indexed citations
5.
Boursier, Jérôme, Victor de Lédinghen, Vincent Leroy, et al.. (2010). 1046 A NEW FIBROSIS STAGING METHOD PROVIDES VERY ACCURATE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS WITHOUT LIVER BIOPSY. Journal of Hepatology. 52. S405–S405. 1 indexed citations
6.
Boursier, Jérôme, et al.. (2009). 697 PRECISE AND SIMPLE QUANTITATION OF LIVER STEATOSIS BY MRI IN AN ANIMAL MODEL AND IN PATIENTS WITH NAFLD. Journal of Hepatology. 50. S255–S256. 1 indexed citations
7.
Calès, Paul, Fabrice Lainé, Jérôme Boursier, et al.. (2008). Comparison of blood tests for liver fibrosis specific or not to NAFLD. Journal of Hepatology. 50(1). 165–173. 195 indexed citations
8.
Dib, Nina, Anselme Konaté, Frédéric Oberti, & Paul Calès. (2005). Diagnostic non invasif de l'hypertension portale au cours de la cirrhose : Application à la stratégie de la prévention primaire des varices. Gastroentérologie Clinique et Biologique. 29(10). 975–987. 11 indexed citations
9.
Croquet, Vincent, et al.. (2003). [1,1, 1-trichloroethane-induced chronic active hepatitis].. PubMed. 27(1). 120–2.
10.
Calès, Paul. (2001). Vaccination anti-hépatite B et effets secondaires graves : ne pas confondre séquence et conséquence. Gastroentérologie Clinique et Biologique. 25(10). 1 indexed citations
11.
Burtin, Pascal, et al.. (1995). [Evaluation of the teaching of echo-endoscopy. Application to the assessment of invasiveness of cancer of the esophagus and the cardia].. PubMed. 19(1). 15–9. 2 indexed citations
12.
Marcellin, Patrick, M. Pouteau, Marie‐Anne Loriot, et al.. (1995). Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.. Gut. 36(3). 422–426. 10 indexed citations
14.
Calès, Paul. (1992). Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis.. PubMed. 16(6-7). 504–10. 6 indexed citations
15.
Gumucio, Jorge J. & Paul Calès. (1991). How does endoscopic sclerotherapy alter splanchnic hemodynamics?. Hepatology. 13(3). 611–612. 1 indexed citations
16.
Calès, Paul, Hervé Desmorat, J.P. Vinel, et al.. (1990). Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.. Gut. 31(11). 1298–1302. 149 indexed citations
17.
Calès, Paul, et al.. (1987). Hépatite cholestatique au carbimazole.. La Presse Médicale. 16(20). 1005–1005.
19.
Bommelaer, Gilles, et al.. (1984). Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition.. Gut. 25(5). 531–533. 10 indexed citations
20.
Cambar, J., et al.. (1981). Variations circadiennes de l'excrétion des électrolytes et des substances azotées dans l'urine de souris et de rats.. 77(8). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026